Cargando…
Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
INTRODUCTION: The purpose of this study was to evaluate clinical outcomes and drug/administration costs of treatment with tumor necrosis factor inhibitor (TNFi) agents in US veterans with rheumatoid arthritis (RA) initiating TNFi therapy. The analysis compared patients initiating and continuing a si...
Autores principales: | Cannon, Grant W., DuVall, Scott L., Haroldsen, Candace L., Caplan, Liron, Curtis, Jeffrey R., Michaud, Kaleb, Mikuls, Ted R., Reimold, Andreas, Collier, David H., Joseph, George J., Harrison, David J., Sauer, Brian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969320/ https://www.ncbi.nlm.nih.gov/pubmed/27352377 http://dx.doi.org/10.1007/s12325-016-0371-0 |
Ejemplares similares
-
Validation of Diagnostic and Procedural Codes for Identification of Acute Cardiovascular Events in US Veterans with Rheumatoid Arthritis
por: Davis, Lisa A., et al.
Publicado: (2014) -
Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis
por: Sauer, Brian C., et al.
Publicado: (2017) -
Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis
por: Wood, Patrick R, et al.
Publicado: (2018) -
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration
por: Navarro-Millán, Iris, et al.
Publicado: (2016) -
Extraction of Rheumatoid Arthritis Disease Activity Measures From Electronic Health Records Using Automated Processing Algorithms
por: Cannon, Grant W., et al.
Publicado: (2019)